PRDX6 and breast cancer: However, in the ncRNA-eQTL database, only the rs2067079 variant demonstrated a trans-eQTL effect on RP11-713C19.2 (ENSG00000213331.4, PRDX6, peroxiredoxin 6, processed pseudogene) in three cancer types (breast cancer, head and neck carcinoma, and hepatocellular carcinoma) (Supplementary Figure S5).